{
    "clinical_study": {
        "@rank": "69001", 
        "acronym": "RASP-HF", 
        "arm_group": {
            "arm_group_label": "clinical pharmacy intervention", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "Heart failure therapies (e.g. beta blockers) have been successful in decreasing mortality\n      rates, as well as diminishing hospitalizations. Also, pharmacist collaboration has been\n      shown to have a beneficial impact on heart failure related outcomes. Regardless, a high\n      residual event rate is to be noted.\n\n      In our pilot study, we wished to document whether a clinical pharmacist could still play a\n      role in the heart failure management of an elderly inpatient heart failure population."
        }, 
        "brief_title": "Feasibility of Pharmaceutical Interventions in Elderly Heart Failure Patients.", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  75 years or older\n\n          -  diagnosis of previous or new heart failure based on signs and symptoms as  defined by\n             the 'European Society of Cardiology guidelines on acute and chronic heart failure'\n\n          -  diagnosis had to be confirmed  by a recent echocardiogram\n\n        Exclusion Criteria:\n\n          -  not Dutch speaking\n\n          -  treatment restrictions had been applied on admission"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "75 Years"
        }, 
        "enrollment": {
            "#text": "29", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 26, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02149940", 
            "org_study_id": "S55301"
        }, 
        "intervention": {
            "arm_group_label": "clinical pharmacy intervention", 
            "intervention_name": "heart-failure related pharmaceutical intervention", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Elderly", 
            "Frailty", 
            "Polypharmacy", 
            "Medication review", 
            "Clinical pharmacy services"
        ], 
        "lastchanged_date": "May 26, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Leuven", 
                    "country": "Belgium", 
                    "state": "Flemish Brabant", 
                    "zip": "3000"
                }, 
                "name": "University Hospitals Leuven"
            }
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "1", 
        "official_title": "Feasibility of Pharmaceutical Interventions in Elderly Heart Failure Patients: a Pilot Study.", 
        "overall_official": [
            {
                "affiliation": "University Hospitals Leuven", 
                "last_name": "Karolien Walgraeve, PharmD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University Hospitals Leuven", 
                "last_name": "Lorenz R Van der Linden, PharmD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University Hospitals Leuven", 
                "last_name": "Jos Tournoy, MD, PhD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Belgium: Federal Agency for Medicines and Health Products, FAMHP", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "the number of heart-failure related pharmaceutical interventions", 
            "safety_issue": "No", 
            "time_frame": "during hospital stay (average of 14 days)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02149940"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "acceptance rate of the pharmaceutical interventions", 
                "safety_issue": "No", 
                "time_frame": "during hospital stay (average of 14 days)"
            }, 
            {
                "measure": "clinical feasibility of the accepted interventions", 
                "safety_issue": "Yes", 
                "time_frame": "during hospital stay (average of 14 days)"
            }
        ], 
        "source": "Universitaire Ziekenhuizen Leuven", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universitaire Ziekenhuizen Leuven", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}